Please login to the form below

I have forgotten my password

durvulamab

This page shows the latest durvulamab news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca shaken by FDA partial hold on durvalumab trial

Aims to resume trial recruitment as soon as possible after bleeding side effects curb study

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Senior Editorial Assistant – Greater Manchester: DOE

Associate Director: £75, 000-90, 000

Senior Account Executive with progression to Account Manager, Me...: Excellent package

Account Manager / Senior Account Manager: 35, 000-40, 000

CALLING ALL SENIOR HEALTHCARE PR FREELANCERS!!!!! ACCOUNT DIRECT...: EXCELLENT DAY RATES AVAILABLE

Associate Medical Director: Excellent PTO, bonus and 401k package

Account Director: Competitive Salary Offered

Principal Health Economist - North-West: Negotiable

Business Development Director – Health Education: excellent commission

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Account Executive/ Senior Account Executive: competitive Salary Offfered

Senior Account Manager: Competitive Salary Offered

Medical Writer: Salary TBC

Editorial Manager - MedComms: DOE

Senior Developer with management potential, Healthcare Brand Com...: circa £50K

Healthcare Communications Account Directors x 2: Salary TBC

Account Manager / Account Director: Competative

Account Manager: Negotiable

Digital Communications Lead, Healthcare Brand and Medical Commun...: up to £50K

Experienced Medical Writers: Competitive Salary and Benefits

Business Director: Competitive Salary Offered

Account Director – Healthcare Marketing – Berks: Salary TBC

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Systematic Reviewer - Oxford: Negotiable

Medical (Scientific) Director: £120, 000 benefits

Subscribe to our email news alerts

PMHub

Add my company

Dovetail

We're award-winning joint working specialists. We help our clients to transform healthcare through effective collaboration, and deliver work to feel...

Latest intelligence

AstraZeneca’s oncology renaissance: Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis: Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls: ‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...